Oestrogen receptor: a stable phenotype in breast cancer (Q36134377)

12 August 2017

1 reference

22 December 2019

Oestrogen receptor: a stable phenotype in breast cancer (English)

1 reference

12 August 2017

1 reference

22 December 2019

1 reference

22 December 2019

1 reference

1 reference

1 reference

Robertson JF

1

1 reference

PMCID

2074280

12 August 2017

language of work or name

English

0 references

publication date

1 January 1996

6 references

British Journal of Cancer

12 August 2017

13 March 2019

3 April 2019

17 June 2019

21 December 2019

22 December 2019

6 references

12 August 2017

13 March 2019

3 April 2019

17 June 2019

21 December 2019

22 December 2019

73

1 reference

12 August 2017

5-12

1 reference

12 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.2

12 August 2017

0 references

cites work

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Molecular mechanisms of resistance to tamoxifen therapy in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Antiestrogen resistance in ER positive breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptors and survival in early breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Variation of receptor status in cancer of the breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Steroid receptors and other prognostic factors in primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Continuous cultures of fused cells secreting antibody of predefined specificity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Inter-site variation of oestrogen receptors in human breast cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Reproducibility of measurements of oestrogen-receptor concentration in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

The surgical implications of estrophile protein estimations in carcinoma of the breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptors and prognosis in early breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Two-stage model for carcinogenesis: Epidemiology of breast cancer in females.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Transforming growth factors from neoplastic and nonneoplastic tissues

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Steroid-hormone receptors and survival after first relapse in breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Cellular effects of tamoxifen in primary breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Receptors for estrogen and progesterone in breast carcinoma in situ

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Estrogen receptor assay in primary breast cancer and early recurrence of the disease

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Prognostic value of estrogen receptors in primary breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074280

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

5 December 2018

1 reference

12 December 2020

Estrogen receptors in ductal carcinoma in situ of breast

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer

1 reference

12 December 2020

Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer

1 reference

12 December 2020

Changes in multiple or sequential estrogen receptor determinations in breast cancer

1 reference

12 December 2020

Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma

1 reference

12 December 2020

Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer

1 reference

12 December 2020

Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer

1 reference

12 December 2020

Estrogen receptor: A prognostic factor in breast cancer

1 reference

12 December 2020

Sampling Procedures in Estrogen Receptor Determinations

1 reference

12 December 2020

Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy

1 reference

12 December 2020

A Two-Stage Immmunocytochemical Method for Oestrogen Receptor Analysis: Correlation with Morphological Parameters of Breast Carcinomas

1 reference

12 December 2020

Multiple simultaneous and sequential estrogen receptor values in patients with breast cancer

1 reference

12 December 2020

Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer

1 reference

12 December 2020

Monoclonal antibodies as probes for estrogen receptor detection and characterization

1 reference

12 December 2020

Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer

1 reference

12 December 2020

Progesterone and estrogen receptors as prognostic variables in breast cancer

1 reference

12 December 2020

Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer

1 reference

12 December 2020

Estrogen receptor immunohistochemistry in carcinoma in situ of the breast

1 reference

12 December 2020

Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue

1 reference

12 December 2020

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

1 reference

12 December 2020

The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-beta 1 in metastatic human breast cancer: an immunocytochemical study

1 reference

12 December 2020

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

12 December 2020

Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy

1 reference

12 December 2020

Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval

1 reference

12 December 2020

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

12 December 2020

Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer

1 reference

12 December 2020

Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH

1 reference

12 December 2020

Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections

1 reference

12 December 2020

Factors affecting estrogen receptors in breast cancer

1 reference

12 December 2020

Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

1 reference

12 December 2020

Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor

1 reference

12 December 2020

Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer

1 reference

12 December 2020

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

12 December 2020

The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas

1 reference

12 December 2020

Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma

1 reference

12 December 2020

Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples

1 reference

12 December 2020

Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers

1 reference

12 December 2020

Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy

1 reference

12 December 2020

Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates

1 reference

12 December 2020

Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time

1 reference

12 December 2020

Immunocytochemical localization of estrogen receptor in human breast tissue

1 reference

12 December 2020

Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion

1 reference

12 December 2020

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

12 December 2020

Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.2

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

2074280